USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
HUMANETICS CORPORATION
Address:
1550 UTICA AVE. S.
SUITE 770
MINNEAPOLIS, MN 55416
EIN:
411626457
DUNS:
197085517
Number of Employees:
5
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $797,224.00 2

Award List:

Development of Cysteamine as a Medical Radiation Countermeasure

Award Year / Program / Phase:
2009 / SBIR / Phase I
Award Amount:
$600,000.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The detonation by a terrorist of an improvised nuclear device would expose hundreds of thousands of citizens to acute radiation syndrome (ARS), which untreated leads to death. There are currently no approved drugs avail able for the prevention or treatment of… More

IGF::OT::IGF OTHER FUNCTIONS RandD- MEDICAL: BIOMEDICAL (BASIC RESEARCH)

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$197,224.00
Agency:
HHS
Principal Investigator:
Michael Kaytor – 952-400-0404
Abstract:
Lung cancer is the most common cause of cancer-related deaths in the United States. Humanetics will develop BIO 300 as a drug that can be given with radiotherapy for lung cancer to help improve efficacy and to decrease toxicity. The focus of the development will be with non-small cell lung cancers… More